Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose ChemotherapyYuval Shaked, Robert S. Kerbel, Ping Xu et al.|Cancer Research|2016Cited by 58
Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib TherapyOfrat Beyar‐Katz, Yuval Shaked, Anat Reiner‐Benaim et al.|Molecular Cancer Research|2019Cited by 34
Bortezomib‐induced pro‐inflammatory macrophages as a potential factor limiting anti‐tumour efficacyOfrat Beyar‐Katz, Yuval Shaked, Neta Ben-Tsedek et al.|The Journal of Pathology|2016Cited by 25